NCT01425320View on ClinicalTrials.gov

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

Fixed Combination dapsone/adapalene Formulation A Gel

Study medication will be applied once daily for 14 days to the face, upper chest, upper back, and shoulders.

DRUG

Fixed Combination dapsone/adapalene Formulation B Gel

Study medication will be applied once daily for 14 days to the face, upper chest, upper back, and shoulders.

DRUG

dapsone 5% gel

Study medication will be applied twice daily for 14 days to the face, upper chest, upper back, and shoulders.

DRUG

adapalene 0.3% gel

Study medication will be applied once daily for 14 days to the face, upper chest, upper back, and shoulders.

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01425320 - Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne | Biotech Hunter | Biotech Hunter